T&K
30126320.141.71% ( -0.35 )
T&K (301263)
Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and international...
- Open
- 20.65
- High
- 20.98
- Low
- 20.00
- Prev. Close
- 20.49
- Volume
- 48.18K
- Turnover
- 97.55M
- Avg Price
- 20.25
- Bid/Ask Ratio
- --
- Amplitude
- 4.78%
- 52wk High
- 34.10
- Volume Ratio
- 0.58
- Turnover Ratio
- 0.94%
T&K Analyst Rating
View MoreForecast & Rating
Feb 25, 2025Price forecast
¥13.75-31.73%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 29, 2025 at 05:20 AM
T&K: Wholly-owned subsidiary Huabo Kaisheng intends to win the bid for the national centralized procurement of drugs
- Zhitong · Oct 28, 2025 at 05:30 AM
T&K: Net profit loss of 5.6796 million yuan in the third quarter, a decrease of 118.57%
- Zhitong · Sep 25, 2025 at 04:17 AM
T&K: CKBA cream for rosacea indications to conduct seamless Phase II/III adaptive clinical trials
- Zhitong · Sep 18, 2025 at 03:14 AM
T&K: The drug registration application for Methanesulfonic Acid Safinamide Tablets has been accepted
- Zhitong · Sep 4, 2025 at 03:35 AM
T&K: The application for the domestic production drug registration and marketing license of Dydrogesterone Tablets has been accepted
- Zhitong · Aug 20, 2025 at 08:18 AM
T&K released its performance for the first half of the year, with a net profit attributable to the parent company of 37.0848 million yuan, a year-on-year decrease of 56.75%
